Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up
Go back to Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up| (NASDAQ: TVTX) | Delayed: 55.95 +0.84 (1.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.11 | 52 Week High | $ | |||
| Open | $54.43 | 52 Week Low | $ | |||
| Day High | $56.01 | P/E | N/A | |||
| Day Low | $54.13 | EPS | $ | |||
| Volume | 1,603,585 | |||||
